Methylated β-cyclodextrin as P-gp modulators for deliverance of doxorubicin across an in vitro model of blood-brain barrier

被引：45
|
作者：
Tilloy, S
Monnaert, V
Fenart, L
Bricout, H
Cecchelli, R
Monflier, E
机构：
[1] Univ Artois, CNRS, FRE 2485, Lab Physicochim Interfaces & Applicat, F-62307 Lens, France
[2] Univ Artois, Fac Sci Jean Perrin, Blood Brain Barrier Lab, EA 2465, F-62307 Lens, France
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2006年 / 16卷 / 08期
关键词：
cyclodextrin; doxorubicin; P-glycoprotein; blood-brain barrier; cholesterol;
D O I：
10.1016/j.bmcl.2006.01.049
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Co-incubations of various beta-cyclodextrins and doxorubicin have been evaluated on an in vitro model of blood-brain barrier in order to increase the delivery of this P-gp substrate to the brain. Among these cyclodextrins used, the Rame-beta-cyclodextrin and Crysme-beta-cyclodextrin increased the transport by a factor of 2 and 3.7, respectively. This increase was attributed to the cholesterol extraction property of these cyclodextrins from brain capillary endothelial cells leading to a modulation of the P-gp activity. (C) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码：2154 / 2157
页数：4
相关论文
共 50 条
  • [1] Effects of Muscone on the Expression of P-gp, MMP-9 on Blood-Brain Barrier Model In Vitro
    Wang, Guang-Yun
    Wang, Ning
    Liao, Hua-Ning
    CELLULAR AND MOLECULAR NEUROBIOLOGY, 2015, 35 (08) : 1105 - 1115
  • [2] Quaternary Ammonium β-Cyclodextrin Nanoparticles for Enhancing Doxorubicin Permeability across the In Vitro Blood-Brain Barrier
    Gil, Eun Seok
    Li, Jianshu
    Xiao, Huining
    Lowe, Tao Lu
    BIOMACROMOLECULES, 2009, 10 (03) : 505 - 516
  • [3] Potential Regulation Mechanisms of P-gp in the Blood-Brain Barrier in Hypoxia
    Ding, Yidan
    Wang, Rong
    Zhang, Jianchun
    Zhao, Anpeng
    Lu, Hui
    Li, Wenbin
    Wang, Chang
    Yuan, Xuechun
    CURRENT PHARMACEUTICAL DESIGN, 2019, 25 (10) : 1041 - 1051
  • [4] Effects of γ- and hydroxypropyl-γ-cyclodextrins on the transport of doxorubicin across an in vitro model of blood-brain barrier
    Monnaert, V
    Betbeder, D
    Fenart, L
    Bricout, H
    Lenfant, AM
    Landry, C
    Cecchelli, R
    Monflier, E
    Tilloy, S
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 311 (03): : 1115 - 1120
  • [5] The multidrug resistance transporter P-glycoprotein (P-gp) in the blood-brain barrier (BBB)
    Wu, Bin
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2015, 128 (03) : S189 - S189
  • [6] PREDICTION OF P-GP MEDIATED DRUG-DRUG INTERACTION AT THE BLOOD-BRAIN BARRIER
    Chapy, Helene
    Nicolai, Johan
    Viot, Delphine
    Saunders, Kenneth
    Gillent, Eric
    Bonnaillie, Pierre
    Ungell, Anna-Lena
    Nicolas, Jean-Marie
    Chanteux, Hugues
    DRUG METABOLISM AND PHARMACOKINETICS, 2020, 35 (01) : S43 - S43
  • [7] The Use of Microdialysis Techniques in Mice to Study P-gp Function at the Blood-Brain Barrier
    Sziraki, Istvan
    Erdo, Franciska
    Trampus, Peter
    Sike, Mirabella
    Molnar, Petra Magdolna
    Rajnai, Zsuzsanna
    Molnar, Judit
    Wilhelm, Imola
    Fazakas, Csilla
    Kis, Emese
    Krizbai, Istvan
    Krajcsi, Peter
    JOURNAL OF BIOMOLECULAR SCREENING, 2013, 18 (04) : 430 - 440
  • [8] Effects of NMDA receptor modulators on a blood-brain barrier in vitro model
    Neuhaus, Winfried
    Freidl, Michael
    Szkokan, Phillip
    Berger, Michael
    Wirth, Michael
    Winkler, Johannes
    Gabor, Franz
    Pifl, Christian
    Noe, Christian R.
    BRAIN RESEARCH, 2011, 1394 : 49 - 61
  • [9] Zinc transport across an in vitro blood-brain barrier model
    Bobilya, DJ
    Guerin, JL
    Rowe, DJ
    JOURNAL OF TRACE ELEMENTS IN EXPERIMENTAL MEDICINE, 1997, 10 (01): : 9 - 18
  • [10] MORPHINE ENHANCES DOXORUBICIN UPTAKE IN AN IN VITRO MODEL OF BLOOD-BRAIN BARRIER
    Iorio, A.
    da Ros, M.
    Lucchesi, M.
    Guidi, M.
    Facchini, L.
    Genitori, L.
    Sardi, I.
    NEURO-ONCOLOGY, 2016, 18 : 27 - 27
12345